1. Home
  2. VTOL vs EOLS Comparison

VTOL vs EOLS Comparison

Compare VTOL & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bristow Group Inc.

VTOL

Bristow Group Inc.

HOLD

Current Price

$36.65

Market Cap

1.0B

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$6.67

Market Cap

444.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTOL
EOLS
Founded
N/A
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Transportation Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
444.0M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
VTOL
EOLS
Price
$36.65
$6.67
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$20.50
AVG Volume (30 Days)
148.5K
843.1K
Earning Date
11-04-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
148.42
N/A
EPS
4.78
N/A
Revenue
$1,466,774,000.00
$285,823,000.00
Revenue This Year
$7.31
$14.24
Revenue Next Year
$9.55
$21.77
P/E Ratio
$7.67
N/A
Revenue Growth
2.95
15.10
52 Week Low
$25.11
$5.71
52 Week High
$42.89
$17.12

Technical Indicators

Market Signals
Indicator
VTOL
EOLS
Relative Strength Index (RSI) 49.10 43.24
Support Level $36.01 $6.57
Resistance Level $37.00 $6.80
Average True Range (ATR) 0.83 0.22
MACD 0.08 -0.05
Stochastic Oscillator 43.97 12.34

Price Performance

Historical Comparison
VTOL
EOLS

About VTOL Bristow Group Inc.

Bristow Group Inc is the provider of vertical flight solutions. The group provides aviation services to a broad base of offshore energy companies and government entities. Its business comprises three reportable segments: Offshore Energy Services, Government Services, and Other Services. Its customers in Australia, Brazil, Canada, Chile, the Dutch Caribbean, the Falkland Islands, India, Ireland, the Kingdom of Saudi Arabia, Mexico, the Netherlands, Nigeria, Norway, Spain, Suriname, Trinidad, the UK, and the U.S. offshore energy customers use services to transport personnel to, from and between offshore energy installations.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: